Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 1;92(4):703-710.
doi: 10.1002/ccd.27387. Epub 2017 Oct 31.

Differential responses to larger volume intra-aortic balloon counterpulsation: Hemodynamic and clinical outcomes

Affiliations

Differential responses to larger volume intra-aortic balloon counterpulsation: Hemodynamic and clinical outcomes

David A Baran et al. Catheter Cardiovasc Interv. .

Abstract

Objectives: Examine hemodynamic and clinical correlates of use of an intra-aortic balloon pump catheter in a single center.

Background: The intra-aortic balloon pump catheter (IABC) has been used for 50 years but the clinical benefit is still debated. We reviewed 76 patients with right heart catheter measurements prior to IABC to assess response and outcomes.

Methods: All patients who received IABC with a 50cc balloon for at least 1 hour were included in this retrospective chart review study. Demographics, comorbidities, lab values, and hemodynamic parameters were recorded at baseline and 15 h postinsertion.

Results: Seventy-six patients had paired measurements of cardiac output. 60 patients had a higher cardiac output with IABC treatment (responder group) and 16 did not (nonresponders). In the 60 patients in the responder group, cardiac output and index significantly increased from baseline 3.6 ± 1.3 L/min to 5.2 ± 1.8 L/min, and 1.8 ± 0.5 L/min/m2 to 2.6 ± 0.8 L/min/m2 respectively following IABC placement (P < 0.0001 for both comparisons). Various hemodynamic variables were examined and the best predictor of response to IABC was a cardiac power index of 0.3 or less. Regardless of response, in hospital survival was similar between groups.

Conclusions: The majority of patients improve their cardiac output with IABC but survival was unchanged. Further work into the pathophysiology of cardiogenic shock is needed.

Keywords: cardiogenic shock; counterpulsation; mortality; systolic heart failure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Panel A: The change in cardiac output between baseline and timepoint A is illustrated with medians and intraquartile ranges graphically illustrated (for both the “responders” and “nonresponders”). Panel B: A parallel plot illustrating the change in cardiac output between baseline and timepoint A showing a line for each patient (for both the “responders” and “nonresponders”). Panel C: A scatterplot illustrating the relationship between baseline cardiac index and the cardiac index post‐ IABC treatment. The vertical line is at 2.2 L/min/M2, which is a definition of cardiogenic shock. Panel D: A scatterplot illustrating the relationship between baseline cardiac power index and the cardiac power index post‐ IABC treatment. The vertical line is at 2.2 L/min/M2, which is a definition of cardiogenic shock
Figure 2
Figure 2
Kaplan‐Meier plot of survival following IABC placement, separated according to treatment (bridge to transplant, bridge to recovery, bridge to mechanical circulatory support or no escalation). The patients who were bridged to durable mechanical circulatory support or heart transplant had 100% survival over the period of observation
Figure 3
Figure 3
Bar graph illustrating the percentage of patients who transitioned to higher levels of support, recovered or were not transitioned from IABC therapy
Figure 4
Figure 4
Kaplan‐Meier plot of survival divided based on “responder”/“nonresponder” status
Figure 5
Figure 5
Kaplan‐Meier plot of survival divided based on whether the IABC was placed for a diagnosis of cardiogenic shock or not

Comment in

Similar articles

Cited by

References

    1. Visveswaran GK, Cohen M, Seliem A, DiVita M, McNamara JK, Dave A, et al. A single center tertiary care experience utilizing the large volume mega 50cc intra‐aortic balloon counterpulsation in contemporary clinical practice. Cathet Cardiovasc Interv 2017;90:E63–E72. - PubMed
    1. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott‐Flugel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra‐aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008;52:1584–1588. - PubMed
    1. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, et al. Randomized comparison of intra‐aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26:1276–1283. - PubMed
    1. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004;44:340–348. - PubMed
    1. Rigamonti F, Graf G, Merlani P, Bendjelid K. The short‐term prognosis of cardiogenic shock can be determined using hemodynamic variables: a retrospective cohort study*. Crit Care Med 2013;41:2484–2491. - PubMed